LISDEXAMFETAMINE Spirig HC caps 70 mg bte 30 pce

7680690310066 CH-69031 N06BA12 01.10.2.
LISDEXAMFETAMINE Spirig HC caps 70 mg bte 30 pce
LISDEXAMFETAMINE Spirig HC caps 70 mg bte 30 pce
LISDEXAMFETAMINE Spirig HC caps 70 mg bte 30 pce
1 / 3
google

Details

Product number
6903106
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
lisdexamfetamini dimesilas 70 mg corresp. dexamfetaminum 20.8 mg, cellulosum microcristallinum, magnesii stearas, carmellosum natricum conexum corresp. natrium 0.79 mg, Kapselhülle: gelatina, E 171, E 127, E 104, E 133, aqua purificata, Drucktinte: lacca, propylenglycolum, E 171, E 172 (nigrum), pro capsula.

Articles (1)

Lisdexamfetamin Spirig HC 70 mg, Hartkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/01/2025
Patient information leaflet
Français
18/01/2025
Patient information leaflet
Italien
18/01/2025
Professional SmPC
Allemand
18/01/2025
Professional SmPC
Français
18/01/2025
Professional SmPC
Italien
18/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.8 MG Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.79 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69031
Drug name
Lisdexamfetamin Spirig HC, Hartkapseln
Galenic form
KAHA
ATC Code
N06BA12
Authorization status
Z
Dispensation category
A+
First authorization
28/03/2024
Authorization expiration date
27/03/2029
IT number
01.10.2.
Domain
Human medicine
Field of application
Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS)

Packaging details

Description (FR)
LISDEXAMFETAMINE Spirig HC caps 70 mg bte 30 pce
Description (DE)
LISDEXAMFETAMIN Spirig HC Kaps 70 mg Ds 30 Stk
Market launch
28/03/2024
Narcotic (BTM)
A

Other packaging sizes

LISDEXAMFETAMINE Spirig HC caps 20 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 30 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 40 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 50 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 60 mg bte 30 pce
30 KAP
View